Penn Virginia Corporation (PVAHQ) 0.0210 $PVAHQ Penn

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Penn Virginia Corporation (PVAHQ) 0.0210 $PVAHQ

Penn Virginia Corporation Emerges From Bankruptcy
Marketwire Canada - Mon Sep 12, 5:32PM CDT
Company has Commitment for up to $200 Million in New Financing and Closes on a $50 Million Rights Offering; Establishes Board of Directors Led by Chairman Harry Quarls

Milbank Advises Noteholders in $1.3 Billion Reorganization of Independent Energy Producer Penn Virginia
PR Newswire - Wed Aug 17, 7:30AM CDT
Milbank, Tweed, Hadley & McCloy LLP advised the Ad Hoc Committee of Noteholders of independent energy producer Penn Virginia Corp. ("Penn Virginia" or the "Company", whose Chapter 11 reorganization plan was approved by a U.S. Bankruptcy Court judge on August 11, 2016.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Exploring the $2.7 Billion Bid for Papa John’s: An Investment Insight

Updated Category News Views 229

Papa John’s $2.7 Billion Takeover Bid: Insights into Potential Value Recently, shares of Papa John’s International Inc (NASDAQ:PZZA) experienced a notable surge, leading to a halt in trading due to high volatility. This surprising movement came in light of credible reports suggesting a take-private cash offer of $65 per share from TriArtisan Capital Advisors, totaling...

Continue Reading
Key Highlights from Octopus Apollo VCT plc AGM Results

Updated Category News Views 105

Octopus Apollo VCT plc AGM Results Overview Octopus Apollo VCT plc recently conducted its Annual General Meeting (AGM), showcasing significant engagement from shareholders. The meeting aimed to discuss key resolutions impacting the future direction of the company. Voting Outcomes of the AGM The company disclosed that all resolutions were successfully passed during the...

Continue Reading
Carisma Therapeutics Showcases Strong Financial Performance

Updated Category News Views 104

Carisma Therapeutics Showcases Strong Financial Performance Carisma Therapeutics Inc. (NASDAQ: CARM), a clinical-stage biopharmaceutical company, recently released its financial performance for the third quarter of 2024. With a focus on developing innovative immunotherapies, Carisma provided insight into its ongoing projects. Key Developments and Milestones Carisma's...

Continue Reading
Epinephrine Market Growth Insights and Future Potential

Updated Category News Views 112

Overview of the Epinephrine Market The global epinephrine market is on a significant upswing, with recent evaluations estimating its value at USD 3.11 billion and a projected growth to approximately USD 6.39 billion within the next decade. As a critical hormone and neurotransmitter produced by the adrenal glands, epinephrine is essential in treating severe allergic...

Continue Reading
Canadian North Resources Achieves Major Milestones in Q2 2025

Updated Category News Views 183

Canadian North Resources Makes Significant Progress in Operational Strategy Highlights: Canadian North has expanded its bio-metallurgical programs significantly, achieving impressive nickel and cobalt extraction rates through innovative bio-leaching tests. The focus remains on extracting copper and other precious group elements (PGE) metals from the Ferguson Lake Project....

Continue Reading